Mr. Abdullah H. AL-Hatareshah is a Clinical pharmacist; He is appointed as the Executive Director for Regulatory Affairs at the Saudi Food and Drug Authority (SFDA).
Prior to this, Mr. AL-Hatareshah was the Director of the Product Licensing Department and Director of the Clinical Trial Department.
Mr. AL-Hatareshah is active member with ICH, he started as a member of ICH expert working group (E17 EWG) since 2014 and now he is ICH Assembly member and IPRP committee member. He was a member of the National Committee of Bio Ethics. Mr. AL-Hatareshah has diversified experience in clinical trial regulation, evaluation, and drug regulatory affairs processes.